deoxycytidine has been researched along with Infusion Site Adverse Event in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, R; Masatsugu, A; Okuda, H; Sijimaya, T | 1 |
1 other study(ies) available for deoxycytidine and Infusion Site Adverse Event
| Article | Year |
|---|---|
Skin Necrosis Due to the Extravasation of Irritant Anticancer Agents.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Infusions, Intravenous; Injection Site Reaction; Irritants; Lymphoma; Male; Necrosis; Skin | 2018 |